Hantz Financial Services’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
Hantz Financial Services's HCAT Position: Q1 2022 in Review
Hantz Financial Services sold out of Health Catalyst (HCAT) in Q1 2022, closing a stake of 13,233 shares — an estimated $524K sold.
Hantz Financial Services first reported a position in HCAT in Q1 2021 and held it in 4 quarters. The position peaked at $524K in Q4 2021. 185 funds tracked by Wall St. Rank hold HCAT as of Q1 2022.
- Hantz Financial Services reported no remaining Health Catalyst position as of Q1 2022 after selling out during the quarter.
- Hantz Financial Services sold 13,233 Health Catalyst shares in Q1 2022, an estimated $524K.
- Hantz Financial Services first reported a position in Health Catalyst in Q1 2021 and held it in 4 quarters.
- Hantz Financial Services's Health Catalyst position peaked at $524K in Q4 2021.
- 185 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2022.
Based on Hantz Financial Services's 13F filing for Q1 2022, filed 23 Aug 2022.